Yearly zoledronic acid in postmenopausal osteoporosis.

Yearly zoledronic acid in postmenopausal osteoporosis.

書誌詳細
主要な著者:	Poole, K, Kaptoge, S, Reeve, J
フォーマット:	Journal article
言語:	English
出版事項:	2007

類似資料

EFFECT OF ZOLEDRONIC AND IBANDRONIC ACIDS ON BONE METABOLISM IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS
著者:: O V Yakushevskaya, 等
出版事項: (2012-08-01)

Treatment of postmenopausal osteoporosis, patient perspectives &ndash; focus on once yearly zoledronic acid
著者:: Raj Carmona, 等
出版事項: (2009-07-01)

IDUA Gene Variants and Response to Zoledronic Acid Treatment in Chinese Women with Postmenopausal Osteoporosis
著者:: Lin H, 等
出版事項: (2021-07-01)

Risk factors analysis in postmenopausal osteoporosis fragility fracture patients after treated with zoledronic acid
著者:: Ding Yue, 等
出版事項: (2017-09-01)

Intravenous zoledronate for postmenopausal women with osteopenia and osteoporosis: a systematic review and metanalysis
著者:: Fernanda Martins Gazoni, 等
出版事項: (2023-05-01)

Zoledronic acid does not slow spinal radiographic progression of osteoarthritis in postmenopausal women with osteoporosis and radiographic osteoarthritis
著者:: L.V. Host, 等
出版事項: (2022-03-01)

Evaluating the Clinical Efficacy of Zoledronic Acid in the Prevention and Treatment of Osteoporosis in Postmenopausal Women, Compared with Conventional Medications
著者:: Fatemeh Rostami-Golmohammadi, 等
出版事項: (2015-02-01)

Role of zoledronic acid in the prevention and treatment of osteoporosis
著者:: Räkel A, 等
出版事項: (2011-03-01)

Zoledronic acid infusion for prevention and treatment of osteoporosis
著者:: John A Sunyecz
出版事項: (2010-10-01)

Zoledronic acid in the treatment of osteoporosis: indications for use
著者:: Nataliya Vladimirovna Toroptsova, 等
出版事項: (2011-06-01)

Zoledronic acid in the treatment of osteoporosis: indications for use
著者:: Nataliya Vladimirovna Toroptsova, 等
出版事項: (2011-06-01)

The Combination Therapy with Zoledronic Acid and Propranolol Improves the Trabecular Microarchitecture and Mechanical Property in an Rat Model of Postmenopausal Osteoporosis
著者:: Deepak Kumar Khajuria, 等
出版事項: (2014-01-01)

The effects of zoledronic acid treatment on depression and quality of life in women with postmenopausal osteoporosis: A clinical trial study
著者:: Feyzi Gokosmanoglu, 等
出版事項: (2016-01-01)

Management of osteoporosis in the aging male: Focus on zoledronic acid
著者:: Paul K Piper Jr, 等
出版事項: (2009-06-01)

Cardiovascular Safety in Postmenopausal Women and Men With Osteoporosis Treated With Denosumab and Zoledronic Acid: A Post‐Authorization Safety Study
著者:: Leslie Spangler, 等
出版事項: (2023-10-01)

Cost-Effectiveness of Sequential Denosumab/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China
著者:: Ruxu You, 等
出版事項: (2022-03-01)

Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D
著者:: Federica Bellone, 等
出版事項: (2021-11-01)

How zoledronic acid improves osteoporosis by acting on osteoclasts
著者:: Biao Wang, 等
出版事項: (2022-08-01)

ZOLEDRONIC ACID IN THE TREATMENT OF OSTEOPOROSIS AND OTHER SKELETAL DISORDERS
著者:: S Yu Vorotnikova, 等
出版事項: (2016-12-01)

Generic zoledronic acid for osteoporosis: focus on tolerability and safety
著者:: N. V. Toroptsova, 等
出版事項: (2021-10-01)

Role of zoledronic acid in treatment of osteoporosis and prevention of fractures
著者:: A. V. Krivova, 等
出版事項: (2022-01-01)

Zoledronate prevents bone loss after stroke
著者:: Poole, K, 等
出版事項: (2006)

The effects of zoledronate on iliac bone remodelling in stroke patients
著者:: Poole, K, 等
出版事項: (2007)

Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis
著者:: Ege Can Serefoglu, 等
出版事項: (2010-05-01)

Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management
著者:: Luca Dalle Carbonare, 等
出版事項: (2010-08-01)

Once-yearly zoledronic acid 5 mg therapy for osteoporosis: a focus on a patient
著者:: Irina Aleksandrovna Baranova, 等
出版事項: (2011-09-01)

Once-yearly zoledronic acid 5 mg therapy for osteoporosis: a focus on a patient
著者:: Irina Aleksandrovna Baranova, 等
出版事項: (2011-09-01)

Preserving hip bone mineral density following stroke using intravenous zoledronic acid: Findings from a 1 year randomised controlled trial
著者:: Poole, K, 等
出版事項: (2004)

Pathogenesis and treatment of postmenopausal osteoporosis
著者:: Milhaud, G, 等
出版事項: (1983)

Effect of zoledronic acid on muscle metabolism in mice with osteoporosis combined with sarcopenia
著者:: Weilong Li, 等
出版事項: (2024-11-01)

Annual Zoledronic Acid for the Treatment of Osteoporosis: A Randomized Controlled Trial
著者:: Asif Hussain, 等
出版事項: (2023-01-01)

Zoledronic acid: challenges and pitfalls amid rehabilitation in primary osteoporosis and beyond
著者:: Alexandru Florin Florescu, 等
出版事項: (2024-06-01)

Single Dose Therapy of Zoledronic Acid for the Treatment of Transient Osteoporosis of Hip
著者:: Sanjay Agarwala, 等
出版事項: (2019-06-01)

Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients
著者:: Jun Xie, 等
出版事項: (2019-12-01)

Development of clinical utility of zoledronic acid and patient considerations in the treatment of osteoporosis
著者:: Johann D Ringe
出版事項: (2010-06-01)

Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture
著者:: Rol, 等
出版事項: (2009-01-01)

EFFECT OF ZOLEDRONIC ACID THERAPY ON FRACTURE RISK IN THE TREATMENT OF MEN WITH OSTEOPOROSIS
著者:: Steven Boonen, 等
出版事項: (2012-12-01)

Retrospective Study of the Effects of Zoledronic Acid on Muscle Mass in Osteoporosis Patients
著者:: Huang CF, 等
出版事項: (2021-08-01)

The effects of zoledronate on iliac bone remodelling; a histomorphometric study in stroke patients
著者:: Poole, K, 等
出版事項: (2007)

Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project
著者:: F. Bertoldo, 等
出版事項: (2011-06-01)